<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23217062</article-id>
      <article-id pub-id-type="pmc">3542249</article-id>
      <article-id pub-id-type="publisher-id">1746-1596-7-173</article-id>
      <article-id pub-id-type="doi">10.1186/1746-1596-7-173</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Prostatic stromal sarcoma with neuroectodermal differentiation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Yamazaki</surname>
            <given-names>Hitoshi</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>powder1104@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Ohyama</surname>
            <given-names>Teppei</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>teturoch@hotmail.co.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Tsuboi</surname>
            <given-names>Toshiki</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>toshiki-t@nyc.odn.ne.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Taoka</surname>
            <given-names>Yoshinori</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>taokay@insti.kitasato-u.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Kohguchi</surname>
            <given-names>Dai</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>ro-calcio-kean-di-daissimo@hotmail.co.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Iguchi</surname>
            <given-names>Hiroyoshi</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>h-iguchi@ax.em-net.ne.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Ao</surname>
            <given-names>Teruaki</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>ao-t@insti.kitasato-u.ac.jp</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Pathology, Medical center hospital, Kitasato Institute, Kitasato University, Saitama, Japan</aff>
      <aff id="I2"><label>2</label>Department of Urology, Medical center hospital, Kitasato Institute, Kitasato University, Saitama, Japan</aff>
      <aff id="I3"><label>3</label>Department of Radiology, Medical center hospital, Kitasato Institute, Kitasato University, Saitama, Japan</aff>
      <pub-date pub-type="collection">
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>7</day>
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <volume>7</volume>
      <fpage>173</fpage>
      <lpage>173</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>9</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>10</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2012 Yamazaki et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <copyright-holder>Yamazaki et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.diagnosticpathology.org/content/7/1/173"/>
      <abstract>
        <sec>
          <title>Abstract</title>
          <p>Prostatic stromal sarcoma is a fairly rare tumor that constitutes approximately 0.1&#x2013;0.2% of all prostatic cancers. Detailed characteristics of the tumor are still unclear due to its rarity.</p>
          <p>We describe a case of prostatic stromal sarcoma in a 63 year-old man who suffered from urinary obstructive symptoms. Palliative transuterine resection was performed and the preliminary histopathological diagnosis was neuroendocrine carcinoma. After chemotherapy, total pelvic exenteration was performed. Histopathologically, the tumor was composed of monotonously proliferating small to medium-sized round cells, which existed in compact islands with loose or dense fibrovascular networks. Immunohistochemically, the tumor cells were widely positive for vimentin, CD56, CD99 and focally positive for synaptophysin, CD10, progesterone receptor, desmin and CD34, but negative for EMA, cytokeratin, estrogen receptor, S-100 and myoglobin. Most of the previously reported tumors exhibited positive stainability for CD10 and progesterone receptor. In addition to these markers, expressions of CD56, CD99 and synaptophysin were characteristically detected in our case. To the best of our knowledge, we present the first case of prostatic stromal sarcoma with characteristic immunohistochemical staining properties. Although the biological characteristics of this rare tumor have not yet been elucidated, these findings suggest prostatic stromal sarcoma can potentially show neuroectodermal differentiation.</p>
        </sec>
        <sec>
          <title>Virtual slide</title>
          <p>The virtual slide(s) for this article can be found here:
<ext-link ext-link-type="uri" xlink:href="http://www.diagnosticpathology.diagnomx.eu/vs/7291874028051262">http://www.diagnosticpathology.diagnomx.eu/vs/7291874028051262</ext-link></p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Prostatic stromal sarcoma</kwd>
        <kwd>STUMP</kwd>
        <kwd>Immunohistochemistry</kwd>
        <kwd>CD99</kwd>
        <kwd>CD56</kwd>
        <kwd>Synaptophysin</kwd>
        <kwd>Neuroectodermal differentiation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Prostatic stromal sarcoma (PSS) is a fairly rare tumor, constituting approximately 0.1% of all prostatic cancers
[<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Prostatic sarcoma and related proliferative lesions, including prostatic phyllodes tumors, have been classified as prostatic stromal tumors of uncertain malignant potential (STUMP) and prostatic stromal sarcoma (PSS) based on cellularity, mitotic index, cellular atypia and necrosis (WHO 2004)
[<xref ref-type="bibr" rid="B3">3</xref>]. Some STUMP cases were reported as malignant transformation into PSS
[<xref ref-type="bibr" rid="B4">4</xref>]. There has not yet been a clear differentiation between PSS and STUMP due to the rarity of these tumors. In this article, prostatic stromal sarcoma has potentially neuroectodermal characteristics.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>The patient was a 63 year-old man who presented to the urologist with a one week history of dysuria, pollakiuria and an unrelieved feeling after urination. He had a previous history of diabetes mellitus and asymptomatic multiple brain infarction. He habitually drank alcohol and smoked and his mother died of gastric cancer. Abdominal ultrasonography revealed 343 ml of residual urine volume. Computed tomography revealed a prostatic mass lesion which protruded into the bladder space (Figure
<xref ref-type="fig" rid="F1">1a</xref>). Gadrinium-enhanced T1 weighted magnetic resonance imaging also revealed the prostatic mass lesion had irregularly high signals (Figure
<xref ref-type="fig" rid="F1">1b</xref>). Based on our clinical diagnosis of benign prostatic hypertrophy, palliative transurethral resection was performed. The specimen consisted of 20 grams of piecemealed prostate that was totally embedded in paraffin and histologically analyzed. Sections showed monotonously proliferating small to medium-sized round cells invading the edematous stroma with coarseness and fineness and sparse or dense patterns. The residual prostatic glands were identified. Immunohistochemically, the tumor cells were positive for vimentin, CD56, synaptophysin (focal) but negative for EMA, cytokeratin, S-100. The preliminary histopathological diagnosis to decide the strategy for further therapy was neuroendocrine carcinoma. He took one series of chemotherapy, a combination of cisplatin and irinotecan. Ten days after the last day of the chemotherapy, suprapubital radical cystprostatectomy with rethrotectomy was performed. During the operation, the urinary bladder could be detached from the rectum with difficulty. Finally, low anterior rectal resection was additionally performed, resulting in total pelvic exenteration. When the urethra was cut, a part of the tumor was pressed down from the urethral cavity. The gross features of the tumor were elastic soft and translucently whitish in color. After fixation in 10% formaldehyde the prostate weighed 125 g and contained an ill-defined gray whitish mass lesion, which focally exhibited necrosis (Figure
<xref ref-type="fig" rid="F2">2</xref>). The bladder and the retroperitoneal cavity were diffusely infiltrated by the whitish tumor, which was directly connected to the prostatic tumor. Although the rectum was attached to the tumor mass, the rectal parenchyma was free from tumor invasion. The bladder space was occupied by the tumor and narrowed, resulting in a slit-like space. Serial sections were analyzed and revealed a round cell sarcomatous tumor with occasional higher cellularity than that in the previous transuterine resection. Tumor necrosis was occasionally identified. The N/C ratio of the tumor cells was a relatively high grade. Mitotic activity was measured as 12/10 HPF in the higher cellularity area. The residual prostatic glands were compressed to the periphery (Figure
<xref ref-type="fig" rid="F3">3a</xref>). No lymph nodal metastasis was observed. Immunohistochemically, the tumor cells were widely positive for vimentin, CD56, CD99 and focally positive for synaptophysin, CD10, progesterone receptor, desmin and CD34, but negative for EMA, cytokeratin, estrogen receptor, S-100, GFAP and myoglobin (Figure
<xref ref-type="fig" rid="F3">3b</xref>,c,d). The Ki-67 index was about 70%. We finally diagnosed the tumor as prostatic stromal sarcoma. Sixteen months later, the patient is alive without local recurrence or distant metastasis.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Image analysis. </bold><bold>a</bold>) Computed tomography shows a prostatic non-homogenous mass lesion irregularly protrudingd into the bladder space. <bold>b</bold>) Gadrinium-enhanced T1 weighted magnetic resonance imaging shows a heterogeneous hyperintense mass.</p>
        </caption>
        <graphic xlink:href="1746-1596-7-173-1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>Cut surface of the tumor.</bold> The prostate and the bladder space are widely occupied by the tumor tissue, which exhibited a whitish-yellow multinodular appearance with focal necrosis.</p>
        </caption>
        <graphic xlink:href="1746-1596-7-173-2"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p><bold>Microscopic findings. </bold><bold>a</bold>)The tumor was made up of sarcomatoid oval to spindle cells. (HE x 100) <bold>b</bold>) Immunostaining with CD56 showed positive results for tumor cells on the cell membrane (CD56 x 200). <bold>c</bold>) Immunostaining with synaptophysin focally showed positive results for the tumor cells in the cytoplasm (synaptophysin x 200). <bold>d</bold>) Immunostaining with CD99 showed positive results for tumor cells on the cell membrane (CD99 x 200).</p>
        </caption>
        <graphic xlink:href="1746-1596-7-173-3"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Prostatic stromal sarcoma is a rare tumor that constitutes approximately 0.1&#x2013;0.2% of all prostatic cancers
[<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Prostatic mesenchymal tumors sometimes cannot be clearly classified as histological entities due to their rarity
[<xref ref-type="bibr" rid="B5">5</xref>]. Except for prostatic mesenchymal tumors with specialized differentiation, a histologically characteristic classification involves prostatic stromal sarcoma and prostatic stromal proliferation of uncertain malignant potential (STUMP)
[<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. These tumors have been described on the basis of the histological similarity to phyllodes tumors and have to be differentially diagnosed as other specialized types of tumor, such as GIST, leiomyosarcoma, rhabdomyosarcoma(RMS), and fibrosarcoma
[<xref ref-type="bibr" rid="B3">3</xref>]. RMS is the most common sarcoma of the prostate, but is rarely reported in adult patients
[<xref ref-type="bibr" rid="B9">9</xref>]. Prostatic stromal sarcoma and STUMP express female hormone receptors, especially progesterone receptor. These tumors seem to be derived from female hormone-dependent stromal cells
[<xref ref-type="bibr" rid="B10">10</xref>]. Depending on the cellularity, mitosis and necrosis, these two tumors are histologically evaluated. An acceptable histological grading of stromal sarcoma has not yet been proposed due to the rarity of the tumor. Hasegawa reported that the ki-67 index was related to the prognosis of the tumor
[<xref ref-type="bibr" rid="B4">4</xref>].</p>
      <p>Recent immunohistochemical analysis revealed that both prostatic stromal sarcoma and STUMP usually express CD10, CD34 and the progesterone receptor
[<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B12">12</xref>]. This tumor sometimes positively reacts with smooth muscle actin. However, the detailed histopathological characteristics of the tumor cells have not yet been clearly elucidated. Kim reported a case of prostatic stromal sarcoma with rhabdoid features
[<xref ref-type="bibr" rid="B13">13</xref>]. The tumor in our case was positive for CD56, CD99 (to our knowledge the second reported case)
[<xref ref-type="bibr" rid="B14">14</xref>], synaptophysin and negative for EMA and cytokeratin. This is the first description of prostatic stromal sarcoma with immunohistochemically positive stainability for synaptophysin. There are other prostatic non-epithelial malignancies with potential neuroectodermal differentiation such as carcinosarcoma, ectomesenchymoma and primitive neuroectodermal tumor (PNET), which have to be distinguished from our case of prostatic stromal sarcoma. Patient age is a useful marker for differential diagnosis, although PNET and malignant ectomesenchymoma are rarely reported in young adult prostate cancer patients
[<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. Most PNET cases reveal positive immunoreactivity for CD99, but are negative for progesterone receptor. Carcinosarcoma contains elements of epithelial malignancy which exhibit some types of cytokeratins.</p>
      <p>PSS is suspiciously derived from mesenchymal pluripotent stem cells in the prostatic stroma. As few cases of STUMP change to PSS in the history, some genetic transformations are considered to be related to PSS
[<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. Arva showed that some cases of prostatic squamous cell carcinoma were derived from hormonal or radiation-treated prostatic adenocarcinoma
[<xref ref-type="bibr" rid="B20">20</xref>]. Unexpected irradiation may be one of the risk factors of PSS
[<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. Babarovi&#x107; reported a case of high grade angiosarcoma arising in fibroadenoma and suggested the possibility that severe inflammatory reaction, for example silicon granuloma, may cause malignant transformation of stromal cells in the affected area
[<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. These factors may give rise to an exuberant stromal response and cause some genetic events in the mesenchymal pluripotent stem cells. We could classify PSS as two categories, which are <italic>de novo</italic> tumorigenesis and malignant transformation step by step
[<xref ref-type="bibr" rid="B20">20</xref>]. However, there are no authentic molecules which directly cause prostatic stromal tumorigenesis. Fibroblast growth factor 8 (FGF8), the eighth member of the fibroblast growth factor family contains alternatively spliced mRNA isoforms. Fibroblast growth factor 8b(FGF8b) is an androgen-induced growth factor with potent oncogenic activity
[<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B27">27</xref>]. Elo reported the results of prostate-targeted fibroblast growth factor 8b transgenic mice
[<xref ref-type="bibr" rid="B28">28</xref>]. These mice showed progressive changes in prostatic stroma, as well as the prostatic epithelium. Furthermore, FGF8b is the predominant FGF8 spliceform necessary for proper posterior neural formation in Xenopus
[<xref ref-type="bibr" rid="B29">29</xref>]. Amsterdam reported the relationship between fgf8 misregulation and neuronal tumors in Zebrafish
[<xref ref-type="bibr" rid="B30">30</xref>]. This knowledge suggests FBF8b is related to potential neuroectodermal differentiation in prostatic stromal tumorigenesis. Some hormonal imbalances, including androgen imbalance, may cause prostatic stromal progression, which could lead to prostatic stromal neoplasia. We hereby point out that PSS may also possess neuroectodermal characteristics.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>We describe a rare case of prostatic stromal sarcoma (PSS) presenting with characteristic immunohistochemical staining properties. To our knowledge, this case is the first case of PSS with positive stainability for synaptophysin, as well as CD99 and CD56.</p>
      <sec>
        <title>Consent</title>
        <p>Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of Diagnostic Pathology.</p>
      </sec>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>We do not have any competing interests for our manuscript.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contribution</title>
      <p>HY was responsible for data collection and drafted the manuscript. TO, TT, YT, DK and TA made contributions to acquisition of clinical data and performed surgical procedure. HI performed radiological interpretation and helped drafting the manuscript. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="book">
          <name>
            <surname>Bernard</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>John</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Bostwick</surname>
            <given-names>DG</given-names>
          </name>
          <person-group person-group-type="editor">Bostwick GB</person-group>
          <article-title>Soft tissue tumors</article-title>
          <source>Pathology of the Prostate</source>
          <year>1990</year>
          <publisher-name>New York: Churchill Livingstone</publisher-name>
          <fpage>117</fpage>
          <lpage>135</lpage>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="book">
          <name>
            <surname>Bostwick</surname>
            <given-names>DG</given-names>
          </name>
          <name>
            <surname>Eble</surname>
            <given-names>JN</given-names>
          </name>
          <person-group person-group-type="editor">Bostwick DG, Eble JN</person-group>
          <article-title>Neoplasms of the prostate</article-title>
          <source>Urologic Surgical Pathology</source>
          <year>1997</year>
          <publisher-name>Philadelphia: Mosby</publisher-name>
          <fpage>399</fpage>
          <lpage>401</lpage>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="book">
          <name>
            <surname>Cheville</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Algaba</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Boccon-Gibod</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Furusato</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Billis</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lopez-Beltran</surname>
            <given-names>A</given-names>
          </name>
          <person-group person-group-type="editor">Eble JN, Sauter G, Epstein JI, Sesterhenn IA</person-group>
          <article-title>Mesenchymal tumours</article-title>
          <source>Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs</source>
          <year>2004</year>
          <publisher-name>Lyon: IARC Press</publisher-name>
          <fpage>209</fpage>
          <lpage>211</lpage>
          <comment>[World Health Organization Classification of Tumours]</comment>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hasegawa</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yoshikawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Konomoto</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Andou</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Inoue</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nagashima</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Omiya</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ushijima</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Prostatic stromal sarcoma: a case report</article-title>
          <source>Nishinihonhinyokika</source>
          <year>2002</year>
          <volume>64</volume>
          <fpage>619</fpage>
          <lpage>626</lpage>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Herawi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Epstein</surname>
            <given-names>JI</given-names>
          </name>
          <article-title>Specialized stromal tumors of the prostate: a clinicopathologic study of 50 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>2006</year>
          <volume>30</volume>
          <fpage>694</fpage>
          <lpage>704</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200606000-00004</pub-id>
          <pub-id pub-id-type="pmid">16723846</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gaudin</surname>
            <given-names>PB</given-names>
          </name>
          <name>
            <surname>Rosai</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Epstein</surname>
            <given-names>JI</given-names>
          </name>
          <article-title>Sarcomas and related proliferative lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>1998</year>
          <volume>22</volume>
          <fpage>148</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-199802000-00002</pub-id>
          <pub-id pub-id-type="pmid">9500215</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>De Berardinis</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Busetto</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Antonini</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Giovannone</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Di Placido</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Magliocca</surname>
            <given-names>FM</given-names>
          </name>
          <name>
            <surname>Di Silverio</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gentile</surname>
            <given-names>V</given-names>
          </name>
          <article-title>Incidental prostatic stromal tumor of uncertain malignant potential (STUMP): histopathological and immunohistochemical findings</article-title>
          <source>Urologia</source>
          <year>2012</year>
          <volume>79</volume>
          <fpage>65</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="doi">10.1016/j.urology.2012.02.008</pub-id>
          <pub-id pub-id-type="pmid">22388992</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Brolin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Skoog</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ekman</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue</article-title>
          <source>Prostate</source>
          <year>1992</year>
          <volume>20</volume>
          <fpage>281</fpage>
          <lpage>295</lpage>
          <pub-id pub-id-type="doi">10.1002/pros.2990200404</pub-id>
          <pub-id pub-id-type="pmid">1376911</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Waring</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Newland</surname>
            <given-names>RC</given-names>
          </name>
          <article-title>Prostatic embryonal rhabdomyosarcoma in adults. A clinicopathologic review</article-title>
          <source>Cancer</source>
          <year>1992</year>
          <volume>69</volume>
          <fpage>755</fpage>
          <lpage>762</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19920201)69:3&lt;755::AID-CNCR2820690324&gt;3.0.CO;2-Y</pub-id>
          <pub-id pub-id-type="pmid">1730126</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Stoll</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>MW</given-names>
          </name>
          <name>
            <surname>Rosenthal</surname>
            <given-names>DL</given-names>
          </name>
          <article-title>High-grade prostatic sarcoma seen in a catheterized urine specimen: case report and differential diagnosis</article-title>
          <source>Diagn Cytopathol</source>
          <year>2011</year>
          <volume>39</volume>
          <fpage>762</fpage>
          <lpage>766</lpage>
          <pub-id pub-id-type="doi">10.1002/dc.21545</pub-id>
          <pub-id pub-id-type="pmid">20890999</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Colombo</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Ceresoli</surname>
            <given-names>GL</given-names>
          </name>
          <name>
            <surname>Boiocchi</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Taverna</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Grizzi</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Bertuzzi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Santoro</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Roncalli</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Prostatic stromal tumor with fatal outcome in a young man: histopathological and immunohistochemical case presentation</article-title>
          <source>Rare Tumors</source>
          <year>2010</year>
          <volume>31;2</volume>
          <issue>4</issue>
          <fpage>e57</fpage>
          <pub-id pub-id-type="pmid">21139968</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Osaki</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Osaki</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Takahashi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Miyagawa</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Adachi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ito</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Prostatic stromal sarcoma: case report and review of the literature</article-title>
          <source>Pathol Int</source>
          <year>2003</year>
          <volume>53</volume>
          <fpage>407</fpage>
          <lpage>411</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1440-1827.2003.01489.x</pub-id>
          <pub-id pub-id-type="pmid">12787317</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kim</surname>
            <given-names>JY</given-names>
          </name>
          <name>
            <surname>Cho</surname>
            <given-names>YM</given-names>
          </name>
          <name>
            <surname>Ro</surname>
            <given-names>JY</given-names>
          </name>
          <article-title>Prostatic stromal sarcoma with rhabdoid features</article-title>
          <source>Ann Diagn Pathol</source>
          <year>2010</year>
          <volume>14</volume>
          <fpage>453</fpage>
          <lpage>456</lpage>
          <pub-id pub-id-type="doi">10.1016/j.anndiagpath.2009.10.008</pub-id>
          <pub-id pub-id-type="pmid">21074696</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Segawa</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Hamada</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Takahara</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Azuma</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tsuji</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Katsuoka</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Prostatic stromal sarcoma: a case report</article-title>
          <source>Hinyokika Kiyo</source>
          <year>2008</year>
          <volume>54</volume>
          <fpage>29</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="pmid">18260357</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kumar</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Khurana</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Rathi</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Malhotra</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Abhishek</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bahadur</surname>
            <given-names>AK</given-names>
          </name>
          <article-title>Primitive neuroectodermal tumor of prostate</article-title>
          <source>Indian J Pathol Microbiol</source>
          <year>2008</year>
          <volume>51</volume>
          <fpage>386</fpage>
          <lpage>388</lpage>
          <pub-id pub-id-type="doi">10.4103/0377-4929.42518</pub-id>
          <pub-id pub-id-type="pmid">18723965</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Funahashi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yoshino</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hattori</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Ewing&#x2019;s sarcoma/primitive neuroectodermal tumor of the prostate</article-title>
          <source>Int J Urol</source>
          <year>2009</year>
          <volume>16</volume>
          <fpage>769</fpage>
          <pub-id pub-id-type="pmid">19769660</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Paramelle</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Crou&#xE9;</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Dupr&#xE9;</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Rialland</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Saint-Andr&#xE9;</surname>
            <given-names>JP</given-names>
          </name>
          <article-title>Pelvic malignant ectomesenchymoma: a case report</article-title>
          <source>Ann Pathol</source>
          <year>2001</year>
          <volume>21</volume>
          <fpage>344</fpage>
          <lpage>347</lpage>
          <pub-id pub-id-type="pmid">11685134</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Colecchia</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dagrada</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Poliani</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Messina</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pilotti</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Primary primitive peripheral neuroectodermal tumor of the prostate. Immunophenotypic and molecular study of a case</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2003</year>
          <volume>127</volume>
          <fpage>e190</fpage>
          <lpage>193</lpage>
          <pub-id pub-id-type="pmid">12683899</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Watanabe</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yamada</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kato</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Imai</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Nakano</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Araki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Shiraishi</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Malignant phyllodes tumor of the prostate: retrospective review of specimens obtained by sequential transurethral resection</article-title>
          <source>Pathol Int</source>
          <year>2002</year>
          <volume>52</volume>
          <fpage>777</fpage>
          <lpage>783</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1440-1827.2002.01417.x</pub-id>
          <pub-id pub-id-type="pmid">12588447</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Arva</surname>
            <given-names>NC</given-names>
          </name>
          <name>
            <surname>Das</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Diagnostic dilemmas of squamous differentiation in prostate carcinoma case report and review of the literature</article-title>
          <source>Diagn Pathol</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>46</fpage>
          <pub-id pub-id-type="doi">10.1186/1746-1596-6-46</pub-id>
          <pub-id pub-id-type="pmid">21627811</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hossain</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Meiers</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Qian</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>MacLennan</surname>
            <given-names>GT</given-names>
          </name>
          <name>
            <surname>Bostwick</surname>
            <given-names>DG</given-names>
          </name>
          <article-title>Prostatic stromal hyperplasia with atypia: follow-up study of 18 cases</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2008</year>
          <volume>132</volume>
          <fpage>1729</fpage>
          <lpage>1733</lpage>
          <pub-id pub-id-type="pmid">18976007</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bostwick</surname>
            <given-names>DG</given-names>
          </name>
          <name>
            <surname>Egbert</surname>
            <given-names>BM</given-names>
          </name>
          <name>
            <surname>Fajardo</surname>
            <given-names>LF</given-names>
          </name>
          <article-title>Radiation injury of the normal and neoplastic prostate</article-title>
          <source>Am J Surg Pathol</source>
          <year>1982</year>
          <volume>6</volume>
          <fpage>541</fpage>
          <lpage>551</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-198209000-00006</pub-id>
          <pub-id pub-id-type="pmid">7149094</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Babarovi&#x107;</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Zamolo</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Musta&#x107;</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Str&#x10D;i&#x107;</surname>
            <given-names>M</given-names>
          </name>
          <article-title>High grade angiosarcoma arising in fibroadenoma</article-title>
          <source>Diagn Pathol</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>125</fpage>
          <pub-id pub-id-type="doi">10.1186/1746-1596-6-125</pub-id>
          <pub-id pub-id-type="pmid">22185665</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Takenaka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Isobe</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yamaguchi</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kojiro</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Shirouzu</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Angiosarcoma of the Breast with Silicone Granuloma: A Case Report</article-title>
          <source>Kurume Med J</source>
          <year>2009</year>
          <volume>56</volume>
          <fpage>33</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="doi">10.2739/kurumemedj.56.33</pub-id>
          <pub-id pub-id-type="pmid">20103999</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tanaka</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Miyamoto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Minamino</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Takeda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sato</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Matsuo</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Matsumoto</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1992</year>
          <volume>89</volume>
          <fpage>8928</fpage>
          <lpage>8932</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.89.19.8928</pub-id>
          <pub-id pub-id-type="pmid">1409588</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ghosh</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Shankar</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Shackleford</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>T'Ang</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Roy-Burman</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Molecular cloning and characterization of human FGF8 alternative messenger RNA forms</article-title>
          <source>Cell Growth &amp; Differentiation</source>
          <year>1996</year>
          <volume>7</volume>
          <fpage>1425</fpage>
          <lpage>1434</lpage>
          <pub-id pub-id-type="pmid">8891346</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kouhara</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Koga</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kasayama</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kishimoto</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sato</surname>
            <given-names>B</given-names>
          </name>
          <article-title>Transforming activity of a newly cloned androgen-induced growth factor</article-title>
          <source>Oncogene</source>
          <year>1994</year>
          <volume>9</volume>
          <fpage>455</fpage>
          <lpage>462</lpage>
          <pub-id pub-id-type="pmid">8290257</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Elo</surname>
            <given-names>TD</given-names>
          </name>
          <name>
            <surname>Valve</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Sepp&#xE4;nen</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Vuorikoski</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>M&#xE4;kel&#xE4;</surname>
            <given-names>SI</given-names>
          </name>
          <name>
            <surname>Poutanen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kujala</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>H&#xE4;rk&#xF6;nen</surname>
            <given-names>PL</given-names>
          </name>
          <article-title>Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic mice</article-title>
          <source>Neoplasia</source>
          <year>2010</year>
          <volume>12</volume>
          <fpage>915</fpage>
          <lpage>927</lpage>
          <pub-id pub-id-type="pmid">21076617</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fletcher</surname>
            <given-names>RB</given-names>
          </name>
          <name>
            <surname>Baker</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Harland</surname>
            <given-names>RM</given-names>
          </name>
          <article-title>FGF8 spliceforms mediate early mesoderm and posterior neural tissue formation in Xenopus</article-title>
          <source>Development</source>
          <year>2006</year>
          <volume>133</volume>
          <fpage>1703</fpage>
          <lpage>1714</lpage>
          <pub-id pub-id-type="doi">10.1242/dev.02342</pub-id>
          <pub-id pub-id-type="pmid">16554360</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Amsterdam</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lai</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Komisarczuk</surname>
            <given-names>AZ</given-names>
          </name>
          <name>
            <surname>Becker</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Bronson</surname>
            <given-names>RT</given-names>
          </name>
          <name>
            <surname>Hopkins</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Lees</surname>
            <given-names>JA</given-names>
          </name>
          <article-title>Zebrafish Hagoromo mutants up-regulate fgf8 postembryonically and develop neuroblastoma</article-title>
          <source>Mol Cancer Res</source>
          <year>2009</year>
          <volume>7</volume>
          <fpage>841</fpage>
          <lpage>850</lpage>
          <pub-id pub-id-type="doi">10.1158/1541-7786.MCR-08-0555</pub-id>
          <pub-id pub-id-type="pmid">19531571</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
